BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/6/2021 11:18:51 AM | Browse: 557 | Download: 1212
 |
Received |
|
2021-01-04 13:44 |
|
Peer-Review Started |
|
2021-01-04 13:45 |
|
First Decision by Editorial Office Director |
|
2021-01-25 01:13 |
|
Return for Revision |
|
2021-01-25 01:13 |
|
Revised |
|
2021-01-29 19:05 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-07 12:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-07 20:52 |
|
Articles in Press |
|
2021-04-07 20:52 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-04-23 01:54 |
|
Publish the Manuscript Online |
|
2021-05-06 11:18 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Armando Rojas, Cristian Lindner, Ileana Gonzàlez and Miguel Angel Morales |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Armando Rojas, PhD, Full Professor, Biomedical Research Labs, Medicine Faculty, Catholic University of Maule, 3605 San Miguel Avenue, Talca 3605, Chile. arojasr@ucm.cl |
| Key Words |
COVID-19; Diabetes mellitus; Advanced glycation; Alarmins; Advanced-glycation end-products axis; Inflammation |
| Core Tip |
Compelling evidences support that diabetes mellitus increases the risk of coronavirus disease 2019 complications, as well as the overall syndrome coronavirus 2 case-fatality. Different reports have suggested the putative involvement of several molecular mechanisms underlying this increased risk. We herein discuss the contribution of the activation of the receptor for advanced-glycation end-products axis to the higher risk for severe illness reported in diabetes patients with coronavirus disease 2019. |
| Publish Date |
2021-05-06 11:18 |
| Citation |
Rojas A, Lindner C, Gonzàlez I, Morales MA. Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients. World J Diabetes 2021; 12(5): 590-602 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i5/590.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i5.590 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
